| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |